Upregulated PXDNL promotes invasive breast carcinoma progression

  • 0Department of Blood Transfusion, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, The People's Republic of China.

|

|

Summary

This summary is machine-generated.

High peroxidase-like (PXDNL) expression in breast cancer is linked to poorer survival and reduced immune cell infiltration. PXDNL may serve as a prognostic biomarker or therapeutic target for invasive breast carcinoma.

Area Of Science

  • Oncology
  • Immunology
  • Genomics

Background

  • Invasive breast carcinoma (BRCA) is a significant health concern for women worldwide.
  • The role of peroxidase-like (PXDNL) in BRCA progression remains largely undefined, despite its association with poor prognosis in other cancers.

Purpose Of The Study

  • To investigate the potential carcinogenic role of PXDNL in invasive breast carcinoma.
  • To analyze the correlation of PXDNL expression with prognosis, immune cell infiltration, and related biological pathways in BRCA.

Main Methods

  • Utilized bioinformatic analysis of datasets from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), and UALCAN.
  • Examined PXDNL expression, promoter methylation, immune cell infiltration, immune checkpoint genes, and pathway enrichment.

Main Results

  • PXDNL expression was significantly altered in BRCA, correlating with poorer survival across subtypes.
  • High PXDNL expression was associated with reduced infiltration of various immune cells, including CD8+ T cells and NK cells.
  • PXDNL expression correlated with immune checkpoint genes and modulated key pathways like epithelial-mesenchymal transition and inflammatory signaling.

Conclusions

  • Overexpressed PXDNL is linked to unfavorable prognosis and altered immune microenvironment in BRCA.
  • PXDNL presents potential as a prognostic biomarker and a therapeutic target for invasive breast carcinoma.